Assessment of circulating betatrophin levels in intrahepatic cholestasis of pregnancy

References

• Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120–133.
   PubMed Web of Science ®Google Scholar
• Kirbas A, Biberoglu E, Ersoy AO, et al. The role of interleukin-17 in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2016;29(6):977–981.
   PubMed Web of Science ®Google Scholar
• Kirbas A, Biberoglu E, Daglar K, et al. Neutrophil-to-lymphocyte ratio as a diagnostic marker of intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014;180:12–15.
   PubMed Web of Science ®Google Scholar
• Kirbas A, Daglar K, Timur H, et al. Maternal circulating levels of irisin in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2016;29(21):3483–3487.
   PubMed Web of Science ®Google Scholar
• Martineau M, Raker C, Powrie R, et al. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2014;176:80–85.
   PubMed Web of Science ®Google Scholar
• Martineau MG, Raker C, Dixon PH, et al. The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care. 2015;38(2):243–248.
   PubMed Web of Science ®Google Scholar
• Tseng YH, Yeh YH, Chen WJ, et al. Emerging regulation and function of betatrophin. Int J Mol Sci. 2014;15(12):23640–23657.
   PubMed Web of Science ®Google Scholar
• Abu-Farha M, Abubaker J, Tuomilehto J. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases. Diabetes Metab Res Rev. 2017;33(8):e2919.
   PubMed Web of Science ®Google Scholar
• Wang S, Hong X, Tu Z, et al. Angiopoietin-like protein 8: an attractive biomarker for the evaluation of subjects with insulin resistance and related disorders. Diabetes Res Clin Pract. 2017;133:168–177.
   PubMed Web of Science ®Google Scholar
• Ebert T, Kralisch S, Hoffmann A, et al. Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2014;99(12):E2510–E2517.
   PubMed Web of Science ®Google Scholar
• Hong BS, Liu J, Zheng J, et al. Angiopoietin-like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non-alcoholic fatty liver disease patients. J Diabetes Invest. 2017. DOI:10.1111/jdi.12792
   Web of Science ®Google Scholar
• Erol O, Ellidağ HY, Ayık H, et al. Evaluation of circulating betatrophin levels in gestational diabetes mellitus. Gynecol Endocrinol. 2015;31(8):652–656.
   PubMed Web of Science ®Google Scholar
• Kong FJ, Ma LL, Li G, et al. Circulating betatrophin levels and gestational diabetes mellitus: a systematic review and meta-analysis. PLoS ONE. 2017;12(1):e0169941.
   PubMed Web of Science ®Google Scholar
• Trebotic LK, Klimek P, Thomas A, et al. Circulating betatrophin is strongly increased in pregnancy and gestational diabetes mellitus. PLoS ONE. 2015;10(9):e0136701.
   PubMed Web of Science ®Google Scholar
• Ebert T, Kralisch S, Wurst U, et al. Betatrophin levels are increased in women with gestational diabetes mellitus compared to healthy pregnant controls. Eur J Endocrinol. 2015;173(1):1–7.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
   PubMed Web of Science ®Google Scholar
• Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011;18(6):409–416.
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med. 2015;21(11):702–714.
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Mäentausta O, Ylöstalo P, et al. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol. 1981;88(3):240–245.
   PubMedGoogle Scholar
• Trauner M, Claudel T, Fickert P, et al. Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis. 2010;28(1):220–224.
   PubMed Web of Science ®Google Scholar
• Chiang JY, Pathak P, Liu H, et al. Intestinal farnesoid X receptor and Takeda G protein couple receptor 5 signaling in metabolic regulation. Dig Dis. 2017;35(3):241–245.
   PubMed Web of Science ®Google Scholar
• Chávez-Talavera O, Tailleux A, Lefebvre P, et al. Bile acid control of metabolism and inflammation in obesity, Type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679–1694.e3.
   PubMed Web of Science ®Google Scholar
• Legry V, Francque S, Haas JT, et al. Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects. J Clin Endocrinol Metab. 2017;102(10):3783–3794.
   PubMed Web of Science ®Google Scholar
• González-Regueiro JA, Moreno-Castañeda L, Uribe M, et al. The role of bile acids in glucose metabolism and their relation with diabetes. Ann Hepatol. 2017;16(Suppl. 1):16–21.
   PubMed Web of Science ®Google Scholar
• Kaska L, Sledzinski T, Chomiczewska A, et al. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol. 2016;22(39):8698–8719.
   PubMed Web of Science ®Google Scholar
• Mazidi M, de Caravatto PP, Speakman JR, et al. Mechanisms of action of surgical interventions on weight-related diseases: the potential role of bile acids. Obes Surg. 2017;27(3):826–836.
   PubMed Web of Science ®Google Scholar
• Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424(4):786–792.
   PubMed Web of Science ®Google Scholar
• Yamada H, Saito T, Aoki A, et al. Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes. Endocr J. 2015;62(5):417–421.
   PubMed Web of Science ®Google Scholar
• Sahin Ersoy G, Altun Ensari T, Vatansever D, et al. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile. Gynecol Endocrinol. 2017;33(2):119–123.
   PubMed Web of Science ®Google Scholar
• Qu Q, Zhao D, Zhang F, et al. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome. J Int Med Res. 2017;45(1):193–202.
   PubMed Web of Science ®Google Scholar
• Adamska A, Łebkowska A, Jacewicz M, et al. Serum concentrations of betatrophin and its association with indirect indices of insulin resistance and beta cell function in women with polycystic ovary syndrome. Int J Endocrinol. 2017;2017:2316986.
   PubMed Web of Science ®Google Scholar
• Fu Z, Berhane F, Fite A, et al. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep. 2014;4:5013.
   PubMed Web of Science ®Google Scholar
• Gómez-Ambrosi J, Pascual E, Catalán V, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab: E2004. 2014;99(10):E2004–E2009.
   PubMed Web of Science ®Google Scholar
• Ejarque M, Borlaug M, Vilarrasa N, et al. Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery. Transl Res. 2017;184:35–44.e4.
   PubMed Web of Science ®Google Scholar
• Pascual-Corrales E, Gómez-Ambrosi J, Moncada R, et al. Circulating ANGPTL8/Betatrophin concentrations are increased after surgically induced weight loss, but not after diet-induced weight loss. Obes Surg. 2016;26(8):1881–1889.
   PubMed Web of Science ®Google Scholar
• Guo K, Yu H, Lu J, et al. Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up. Surg Obes Relat Dis. 2016;12(7):1343–1348.
   PubMed Web of Science ®Google Scholar